Who we are

Medicines Australia leads the research-based medicines industry of Australia. Our members discover, develop and manufacture prescription medicine products, biotherapeutic products and vaccines that bring health, social and economic benefits to Australia. Our members are committed to the highest ethical standards as they invest in Australian medical research and take local discoveries and developments to the world.


Our Mission

Ensuring Australians have universal, affordable and fast access to treatments that keep pace with advancements in medicine by working with government, health sector and patient organisations to design and implement the right policy settings.

Our Vision

To make a real difference to the health of Australians by ensuring they have access to world-class medicines when they need them.


Our Strategic Objectives and Priorities

Objectives Priorities
Build stakeholder and community support for the value and benefits (health, social and economic) of new and emerging medicines and vaccines for Australia
  • Identify and build relationships with key stakeholders
  • Deliver a compelling narrative around the value and benefits of innovative medicines and the industry in Australia so that policy decisions support a sustainable industry and early access to new treatments
Ensure new medicines are universally available to Australians when they need them through:

  • Ensuring efficient assessment and evaluation methods to reflect ongoing developments in research, diagnostics and treatment
  • Ensuring funding mechanisms can adapt to meet the needs of, and deliver value to, government, patients and the community
  • Identify and explore improvements to models for evaluating and financing medicines for today and into the future
  • Collaborate with government, health and community partners to develop and achieve implementation of policy options
  • Develop and promote expertise within the industry on policy and funding mechanisms to increase access to medicines and minimise the burden of disease in the Australian community
  • Promote the importance of a positive investment environment for research, clinical trials and manufacturing in Australia to support better health outcomes for Australians, economic growth and innovation

Successful self-regulation

Medicines Australia’s Code of Conduct for advertising and promotion of prescription medicines has been internationally recognised for its effectiveness in regulating these activities.

Adherence to the Code of Conduct is a requirement of membership of Medicines Australia.

The Code of Conduct Committee, with medical, legal and consumer representatives, has the power to direct withdrawal of advertising, require letters of clarification and impose company fines for breaches of the Code.

The Medicines Australia Special Purpose Fund has been established, with funds derived from the surplus of fine income (minus the administrative costs of running the Code of Conduct).


Government relations

Members of Medicines Australia and the Medicines Australia secretariat remain in close contact with Members of Parliament and government departments to monitor activities and promote policy options to ensure the continuation of a viable medicines industry.


Working with consumers

The Australian medicines industry is committed to enhancing its relationship with health consumers. Medicines Australia continues to actively engage with key consumer groups to better understand their needs and issues.

The Working Together Guide and Supplementary Materials, which has been jointly developed by the peak health consumer body, the Consumers’ Health Forum of Australia and Medicines Australia, is a reference tool offering basic principles for collaboration. It includes suggestions that can be adapted to suit the individual needs of consumer organisations.


Working with health professionals

Medicines Australia regularly liaises with health professional organisations to keep up to date with developments in healthcare, and to discuss issues of mutual concern.


Education within the health field

The Continuing Education Program, administered by Medicines Australia, is a compulsory education program for all medical representatives employed in the industry in order to ensure an adequate level of medical and scientific knowledge. This helps health professionals by ensuring that their questions will be appropriately responded to by representatives.

Medicines Australia provides briefings and publications to educate the community about the industry in Australia.

In these education activities, Medicines Australia strongly supports the Government’s National Medicines Policy’s call for appropriate and rational use of medicines.

sdfsdf her eis naother paragraphn


Medicines Australia as a health resource

For its member companies, the Medicines Australia secretariat provides a wide range of services, including:

  • Briefing on policy initiatives and issues
  • Representations to government on behalf of industry
  • Representing the industry at relevant health, medical and research activities
  • Providing specialist advice to member companies
  • Educating the community about industry activities

Scientific and healthcare expertise

The Medicines Australia secretariat and its member companies contribute experience and expertise through participation in a wide range of activities, including membership of advisory committees and participation in health and industry policy development.